Aragon Institute for Health Research (IIS Aragón), Zaragoza, Spain.
Ophthalmology Department, Miguel Servet University Hospital, Pso. Isabel la Católica 3, 350009, Zaragoza, Spain.
Int Ophthalmol. 2022 Mar;42(3):747-756. doi: 10.1007/s10792-021-02040-4. Epub 2021 Oct 7.
Visual acuity is the most used method to assess visual function in children. Contrast sensitivity complements the information provided for visual acuity, but it is not commonly used in clinical practice. Digital devices are increasingly used as a method to evaluate visual function, due to multiple advantages. Testing with these devices can improve the evaluation of visual development in children from a few months of age. Visual acuity and contrast sensitivity tests, using eye tracking technology, are able to measure visual function in children across a wide range of ages, objectively, quickly and without need of an experienced examiner.
To report age-normative values for grating visual acuity and contrast sensitivity in healthy children using a digital device with eye tracking technology and to validate the grating acuity test.
In the first project of the study, we examined healthy children aged between 6 months and 7 years with normal ophthalmological assessment. Grating visual acuity (VA) and contrast sensitivity (CS) were assessed using a preferential gaze paradigm with a DIVE (Device for an Integral Visual Examination) assisted with eye tracking technology to provide age norms. For the validation project, we compared LEA grating test (LGT) with DIVE VA in a group of children aged between 6 months and 4 years with normal and abnormal visual development.
Fifty-seven children (2.86 ± 1.55 years) were examined with DIVE VA test and 44 successfully completed DIVE CS test (3.06 ± 1.41 years). Both, VA and CS values increased with age, mainly along the first two years of life. Sixty-nine patients (1.34 ± 0.61 years) were included in the DIVE VA test validation. The mean difference between LGT and DIVE VA was - 1.05 ± 4.54 cpd with 95% limits of agreement (LoA) of - 9.95-7.84 cpd. Agreement between the two tests was higher in children younger than 1 year with a mean difference of - 0.19 ± 4.02 cpd.
DIVE is an automatic, objective and reliable tool to assess several visual function parameters in children, and it has good agreement with classical VA tests, especially for the first stage of life.
视力是评估儿童视觉功能最常用的方法。对比敏感度补充了视力提供的信息,但在临床实践中并不常用。数字设备越来越多地被用作评估视觉功能的一种方法,因为它们具有多种优势。使用这些设备进行测试可以改善从几个月大的儿童的视觉发育评估。使用眼动跟踪技术的视力和对比敏感度测试能够客观、快速且无需经验丰富的检查者地测量广泛年龄段儿童的视觉功能。
使用具有眼动跟踪技术的数字设备报告健康儿童的光栅视力和对比敏感度的年龄正常值,并验证光栅视力测试。
在研究的第一个项目中,我们检查了年龄在 6 个月至 7 岁之间、眼科评估正常的健康儿童。使用带有眼动跟踪技术的 DIVE(综合视觉检查设备)辅助的优先注视范式评估光栅视力(VA)和对比敏感度(CS),以提供年龄正常值。在验证项目中,我们比较了 LEA 光栅测试(LGT)和 DIVE VA 在一组年龄在 6 个月至 4 岁之间、视觉发育正常和异常的儿童中的结果。
57 名儿童(2.86±1.55 岁)接受了 DIVE VA 测试,44 名儿童成功完成了 DIVE CS 测试(3.06±1.41 岁)。VA 和 CS 值均随年龄增长而增加,主要在前两年。69 名患者(1.34±0.61 岁)纳入 DIVE VA 测试验证。LGT 和 DIVE VA 之间的平均差异为-1.05±4.54 cpd,95%置信区间(LoA)为-9.95-7.84 cpd。在年龄小于 1 岁的儿童中,两种测试之间的一致性更高,平均差异为-0.19±4.02 cpd。
DIVE 是一种自动、客观、可靠的工具,可用于评估儿童的多项视觉功能参数,与经典的 VA 测试具有良好的一致性,尤其是在生命的第一阶段。